How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers. Issue 3 (September 2019)

• Record Type: Journal Article
• Authors: Li, Rebecca; Sim, Ida
• Other Names: Hey Spencer Phillips guest-editor.
• Is Part Of: Journal of law, medicine & ethics. Volume 47:Issue 3(2019)
• Page Start: 369
• Page End: 373
• Publication Date: 2019-09
• Subjects: Medical laws and legislation -- United States -- Periodicals; Medical care -- Law and legislation -- United States -- Periodicals; Medical ethics -- Periodicals; Jurisprudence -- Periodicals; Legislation, Medical -- Periodicals; Legislation, Nursing -- Periodicals; Ethics -- Periodicals; Forensic Medicine -- Periodicals; Nursing -- Periodicals; Medicine -- Periodicals; Societies -- Periodicals; Medical care -- Law and legislation; Medical ethics; Medical laws and legislation; United States; Periodicals; 344.73041
• DOI: 10.1177/1073110519876165
• Languages: English
• ISSNs: 1073-1105

Abstract

Although data sharing platforms host diverse data types the features of these platforms are well-suited to facilitating biomarker research. Given the current state of biomarker discovery, an innovative paradigm to accelerate biomarker discovery is to utilize platforms such as Vivli to leverage researchers' abilities to integrate certain classes of biomarkers.